Intended for Canadian Healthcare Professionals only

Frequently Asked Questions

Home / FAQs

For Canadian healthcare professionals only.

Please note: Local policy and the Product Monograph supersede this FAQ. Follow your hospital’s transfusion and emergency haemostasis guidelines.

Laboratory targets and monitoring

Clauss fibrinogen is the reference. Where available, ROTEM or TEG may guide both the trigger and the effect of therapy with faster turnaround.

For ongoing major bleeding, re-check after the first dose, then at intervals dictated by hemorrhage severity, often every 4 to 6 hours in the first day or at the next viscoelastic cycle.

Consider ongoing consumption, dilution, hyperfibrinolysis, laboratory timing relative to infusion, or sampling issues. Reassess dosing and consult hematology.